Insight Research Group

Insight Research Group has made a number of staff changes. Lee Gazey joins the group at director level.More...

[Published 09 May 2008]

Actelion Pharmaceuticals

Stephanie Kelly has joined Actelion Pharmaceuticals as brand manager for its anti-hypertensive Tracleer.

[Published 09 May 2008]

RSA

More...

[Published 19 December 2007]

RSA

RSA has strengthened its contingency business, RSA Pharmarecruit, with the appointment of four new consultants in the last year, bringing the team to a total of nine.More...

[Published 13 July 2007]

Science|Business

More...

[Published 29 June 2007]

The Excel Academy has appointed Andrew Waiton to the role of head of sales and marketing  opinion leader academy.  Andrew has worked within the pharma and healthcare for 18 years, and spent five years at Innovex in a range of marketing and sales management roles.

[Published 13 February 2007]

Affiniti has made two additions to its management team. Stephen Dunn has ben appointed as commercial director and Neil Smith becomes deputy managing director. Stephen joins from Darwin Grey where he specialized in developing integrated communication programmes including e-learning and CME for key clients includingNovartis, Sanofi-Aventis and Roche.

With over 12 years experience in pharma, Stephen has worked across a wide range of therapy areas from oncology to cardiology. Neil will assume a key managerial role while continuing as the agencys creative services director, and chairman of the Pharmaceutical Marketing Society Awards. 

[Published 13 February 2007]

Paling Walters has appointed two new account directors. Ed Shorthose brings global and local experience covering CVD, diabetes, obesity, ophthalmology and mens health. His business knowledge spans healthcare advertising, medical education and the publishing industry. Steve Morris began his career in consumer advertising, then founded and managed advertising monitor Print Archives for 15 years. Moving into pharmaceuticals three years ago, he has worked with Pfizer, Allergan and Novartis.

[Published 13 February 2007]

Colin Hannah has become managing director of Innovex UK. Colin has a track record in sales and marketing in pharma spanning more than 20 years. Before joining Innovex in 2006, Colin was managing director for Sanofi-Aventis for Australia and New Zealand. This opportunity has arisen because Alison Clough is now responsible for Innovex global operations. Alison will be managing the execution of multi-country and multi-service projects and the development and execution of a global health management strategy

[Published 13 February 2007]

Dr Thierry Le Chevalier is the new vice president, Oncology Medicine Development Centre and scientific advisor for GlaxoSmithKline. Dr Le Chevalier was formerly director, international affairs, at the French National Cancer Institute and has a wealth of oncology experience, especially in lung cancer. Prior to this, he held a number of positions at the Institut Gustave Roussy in France including head of the division of cancer medicine and chief of service, medical oncology.

He has written and contributed to more than 300 publications, presentations and books and he is currently the associate editor of Annals of Oncology and the Journal of Thoracic Oncology. He has previously held the position of chairman of both the Lung Cancer Group of the French Federation of Cancer Centres and  the Scientific Committee of the French Intergroup of Thoracic Oncology.

[Published 13 February 2007]